<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01208584</url>
  </required_header>
  <id_info>
    <org_study_id>306/09</org_study_id>
    <nct_id>NCT01208584</nct_id>
  </id_info>
  <brief_title>Brain Function and White Matter Changes in Congenital, Acute and Chronic Spinal Cord Lesions</brief_title>
  <official_title>Brain Function and White Matter Changes in Congenital, Acute and Chronic Spinal Cord Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to use functional MRI (fMRI) and magnetic resonance (MR)
      diffusion tensor imaging (DTI) to investigate brain activation and white matter changes in
      patients with congenital (birth defect of the spinal column), acute and chronic complete
      spinal cord lesions. The findings of this study may provide a basis to better understand the
      pathomechanisms underlying the dynamic neurofunctional changes following a spinal cord
      lesions in man. This understanding is important for the improvement of existing therapies and
      for the development of new therapeutic approaches.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recently new approaches to spinal cord repair have been successfully established in animal
      models. Promising therapies for promoting spinal axonal regeneration in man will be available
      in the near future. Most research in the field is focussed on the lesion itself and the
      perilesional spinal cord. The recovery of motor and sensory function is,however, not
      permitted by local processes at the spinal level only. The whole central nervous system (CNS)
      reacts to such a condition. Therefore the modulation of motor and sensory function in spinal
      cord lesioned patients should be reflected in characteristic changes of cortical brain
      activity, which are accessible to new non-invasive functional neuroimaging techniques such as
      functional magnetic resonance imaging (fMRI). Changes of white matter due to axonal damage
      can also be measured qualitatively and quantitatively using MR diffusion tensor imaging
      (DTI). Those measures may provide a basis to better understand the pathophysiology underlying
      spinal cord lesions in man, including changes in brain function over time (during
      rehabilitation) or related to specific treatment. However, there are no studies available yet
      addressing those topics or providing mechanism-based approaches for determining the time
      interval of application of novel neuroregenerative drugs. By investigation of brain
      activation and white matter changes in patients with congenital(myelomeningocele (MMC)),
      acute and chronic spinal cord lesions (ASIA A) first and fundamental work in this field will
      be conducted in this study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">22</enrollment>
  <condition>Paraplegia, Spinal</condition>
  <condition>Myelomeningocele</condition>
  <arm_group>
    <arm_group_label>Chronic posttraumatic paraplegia</arm_group_label>
    <description>Paraplegic patients (Thoracic level of lesion Th1-Th12), ASIA A, spinal cord injury (SCI) 12-24 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acute posttraumatic paraplegia</arm_group_label>
    <description>Paraplegic patients (Thoracic level of lesion Th1-Th12), ASIA A,SCI 2-6 months,</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Myelomeningocele patients</arm_group_label>
    <description>Myelomeningocele patients (congenital paraplegia, thoracic level of lesion Th1-Th12) ASIA A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Volunteers</arm_group_label>
    <description>Volunteers without any neurological deficits</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fMRI, DTI</intervention_name>
    <description>functional magnetic resonance imaging (fMRI), MR diffusion tensor imaging (DTI)</description>
    <arm_group_label>Chronic posttraumatic paraplegia</arm_group_label>
    <arm_group_label>Acute posttraumatic paraplegia</arm_group_label>
    <arm_group_label>Myelomeningocele patients</arm_group_label>
    <arm_group_label>Volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  Paraplegic patients (Thoracic level of lesion Th1-Th12), ASIA A

          -  Myelomeningocele patients (congenital paraplegia, thoracic level of lesion Th1-Th12)
             ASIA A

          -  Volunteers without any neurological deficits
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Paraplegic patients (Th1-Th12, ASIA A),

          -  Myelomeningocele patients (Th1-Th12 ASIA A)

          -  Acute SCI 2-6 months, chronic SCI 12-24 months

        Exclusion criteria:

          -  Traumatic brain injury (TBI)

          -  Neurological diseases other than spinal cord lesion

          -  MRI incompatibility

          -  Pressure sores

          -  methicillin-resistant Staphylococcus aureus (MRSA)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Stippich, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basle - Department of Neuroradiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital, Basle (only study site!)</name>
      <address>
        <city>Basle</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 23, 2010</study_first_submitted>
  <study_first_submitted_qc>September 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 24, 2010</study_first_posted>
  <last_update_submitted>March 10, 2015</last_update_submitted>
  <last_update_submitted_qc>March 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>functional MRI,primary motor cortex,spinal cord injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paraplegia</mesh_term>
    <mesh_term>Meningomyelocele</mesh_term>
    <mesh_term>Spina Bifida Cystica</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

